SurModics is a medical devices business based in the US. SurModics shares (SRDX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $39.19 – an increase of 2.67% over the previous week.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $39.19 |
|---|---|
| 52-week range | $25.17 - $42.44 |
| 50-day moving average | $38.50 |
| 200-day moving average | $36.15 |
| Wall St. target price | $43.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.83 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $38.72 from 2024-11-15
| 1 week (2024-11-12) | 0.41% |
|---|---|
| 1 month (2024-10-18) | 1.20% |
| 3 months (2024-08-19) | -3.49% |
| 6 months (2024-05-17) | 11.84% |
| 1 year (2023-11-17) | 10.34% |
|---|---|
| 2 years (2022-11-18) | 13.02% |
| 3 years (2021-11-19) | 48.22 |
| 5 years (2019-11-19) | 39.19 |
Valuing SurModics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SurModics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SurModics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.8952. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into SurModics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
SurModics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.8 million.
The EBITDA is a measure of a SurModics's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $126.1 million |
|---|---|
| Gross profit TTM | $29 million |
| Return on assets TTM | -0.66% |
| Return on equity TTM | -9.67% |
| Profit margin | -9.16% |
| Book value | $8.38 |
| Market Capitalization | $552.4 million |
TTM: trailing 12 months
We're not expecting SurModics to pay a dividend over the next 12 months.
SurModics's shares were split on a 2:1 basis on 6 December 2000 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your SurModics shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for SurModics shares which in turn could have impacted SurModics's share price.
Over the last 12 months, SurModics's shares have ranged in value from as little as $25.17 up to $42.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SurModics's is 1.202. This would suggest that SurModics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Surmodics, Inc. , together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.